Susquehanna International Group
APTO

Susquehanna International Group’s Aptose Biosciences, Inc. APTO Stock Holding History

Susquehanna International Group’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-162
Closed -$99K – 14339
2021
Q4 		$99K Sell
162
-42
-21% -$39.5K ﹤0.01% 12164
2021
Q3 		$200K Buy
204
+16
+9% +$20K ﹤0.01% 11482
2021
Q2 		$281K Buy
+188
New +$410K ﹤0.01% 10911
2021
Q1 		– Sell
-116
Closed -$230K – 13029
2020
Q4 		$229K Sell
116
-34
-23% -$79.9K ﹤0.01% 9813
2020
Q3 		$404K Sell
150
-69
-32% -$172K ﹤0.01% 8109
2020
Q2 		$622K Sell
219
-94
-30% -$303K ﹤0.01% 6902
2020
Q1 		$837K Buy
313
+25
+9% +$74.6K ﹤0.01% 5792
2019
Q4 		$736K Sell
288
-3
-1% -$3.91K ﹤0.01% 6149
2019
Q3 		$273K Buy
291
+189
+185% +$215K ﹤0.01% 8502
2019
Q2 		$120K Buy
102
+79
+343% +$72.7K ﹤0.01% 9520
2019
Q1 		$21K Sell
23
-14
-38% -$12.7K ﹤0.01% 8590
2018
Q4 		$32K Sell
37
-31
-46% -$30.5K ﹤0.01% 8599
2018
Q3 		$80K Sell
68
-30
-31% -$40.2K ﹤0.01% 8684
2018
Q2 		$173K Buy
+98
New +$156K ﹤0.01% 8742

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Susquehanna International Group's APTO Position: Q1 2022 in Review

Susquehanna International Group sold out of Aptose Biosciences, Inc. (APTO) in Q1 2022, closing a stake of 162 shares — an estimated $99K sold.

Susquehanna International Group first reported a position in APTO in Q2 2018 and held it in 14 quarters. The position peaked at $837K in Q1 2020. 52 funds tracked by Wall St. Rank hold APTO as of Q1 2022.

  • Susquehanna International Group reported no remaining Aptose Biosciences, Inc. position as of Q1 2022 after selling out during the quarter.
  • Susquehanna International Group sold 162 Aptose Biosciences, Inc. shares in Q1 2022, an estimated $99K.
  • Susquehanna International Group first reported a position in Aptose Biosciences, Inc. in Q2 2018 and held it in 14 quarters.
  • Susquehanna International Group's Aptose Biosciences, Inc. position peaked at $837K in Q1 2020.
  • 52 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.